Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: A prospective three-year follow-up study

Schizophrenia Research

Volumn 152, Issue 1, 2014, Pages 146-151

  Chang, Wing Chung ^a   Hui, Christy Lai Ming ^a   Chan, Sherry Kit Wa ^a   Lee, Edwin Ho Ming ^a   Wong, Gloria Hoi Yan ^a   Chen, Eric Yu Hai ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cognitive impairment; Diminished expression; First episode schizophrenia; Longitudinal follow up; Negative symptoms

Indexed keywords

ADULT; ARTICLE; CHINESE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIMINISHED EXPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FIRST EPISODE SCHIZOPHRENIA; FOLLOW UP; HONG KONG; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOM; WISCONSIN CARD SORTING TEST; ALOGIA; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; LANGUAGE ABILITY; SPEECH DISORDER; VERBAL FLUENCY;

COGNITIVE IMPAIRMENT; DIMINISHED EXPRESSION; FIRST-EPISODE SCHIZOPHRENIA; LONGITUDINAL FOLLOW-UP; NEGATIVE SYMPTOMS;

ADOLESCENT; ADULT; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; TIME FACTORS; YOUNG ADULT;

EID: 84891631170     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.11.027     Document Type: Article

References (52)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. 4th edition.
2. Bell M.D., Mishara A.L. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr. Res. 2006, 81:17-27.
3. Bell M.D., Corbera S., Johannesen J.K., Fiszdon J.M., Wexler B.E. Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?. Schizophr. Bull. 2013, 39:186-196.
4. Bilder R.M., Goldman R.S., Robinson D., et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157:549-559.
5. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and negative symptoms. Am. J. Psychiatry 2006, 163:418-425.
6. Brewer W.J., Edwards J., Anderson V., et al. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol. Psychiatry 1996, 40:1021-1031.
7. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
8. Cassidy C.M., Norman R., Manchanda R., Schmitz N., Malla A. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2years. Schizophr. Bull. 2010, 36:1001-1008.
9. Censits D.M., Ragland J.D., Gur R.C., Gur G.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 1997, 24:289-298.
10. Chang W.C., Hui C.L.M., Tang J.Y.M., et al. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr. Res. 2011, 133:22-28.
11. Chang W.C., Hui C.L.M., Wong G.H.Y. Persistent negative symptoms in first-episode schizophrenia: clinical stability, predictors, cognitive and functional outcomes. Conference Abstracts of the 5th International Conference on Schizophrenia of the Schizophrenia Research Foundation, Chennai, India 2012, (Abstract, 80).
12. Chang W.C., Hui C.L.M., Tang J.Y.M., et al. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Psychol. Med. 2013, 43:1883-1894.
13. Chang W.C., Tang J.Y.M., Hui C.L.M., et al. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res. 2013, 209:353-360.
14. Chen E.Y.H., Lam L.C.W., Chen R.Y.L., Nguyen D.G.H. Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. Br. J. Psychiatry 1996, 168:227-233.
15. Cohen A.S., Saperstein A.M., Gold J.M., Kirkpatrick B., Carpenter W.T., Buchanan R.W. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr. Bull. 2007, 33:1201-1212.
16. Corcoran C., Whitaker A., Coleman E., et al. Olfactory deficits, cognition and negative symptoms in early onset psychosis. Schizophr. Res. 2005, 80:283-293.
17. Couture S.M., Granholm E.L., Fish S.C. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophr. Res. 2011, 125:152-160.
18. Dominguez M.D.G., Viechtbauer W., Simons C.J.P., van Os J., Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol. Bull. 2009, 135:157-171.
19. Donohoe G., Corvin A., Robertson I.H. Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile. Cogn. Neuropsychiatry 2006, 11:13-32.
20. Evensen J., Rossberg J.I., Barder H., et al. Flat affect and social functioning: a 10year follow-up study of first episode psychosis patients. Schizophr. Res. 2012, 139:99-104.
21. Faerden A., Vaskinn A., Finset A., et al. Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry 2009, 9:1.
22. Friedman J.I., Harvey P.D., McGurk S.R., et al. Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical co-morbidity. Am. J. Psychiatry 2002, 159:1388-1394.
23. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry 1999, 156:1342-1348.
24. Goldberg T.E., Goldman R.S., Burdick K.E., et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it practice effect?. Arch. Gen. Psychiatry 2007, 64:1115-1122.
25. Gonzalez-Blanch C., Crespo-Facorro B., Alvarez-Jimenez M., et al. Lack of association between clinical and cognitive change in first-episode psychosis: the first 6weeks of treatment. Can. J. Psychiatry 2008, 53:839-846.
26. Green M., Neuchterlein K. Should schizophrenia be treated as a neurocognitive disorder?. Schizophr. Bull. 1999, 25:301-309.
27. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26:119-136.
28. Gur R.E., Kohler C.G., Ragland J.D., et al. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr. Bull. 2006, 32:279-287.
29. Hafner H., Riecher-Rossler A., Hambrecht M., et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr. Res. 1992, 6:209-223.
30. Harvey P.D., Lombardi J., Leibman M., et al. Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study. Schizophr. Res. 1996, 22:223-231.
31. Harvey P.D., Green M.F., Bowie C., Loebel A. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology 2006, 187:356-363.
32. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32:250-258.
33. Heydebrand G., Weiser M., Rabinowitz J., Hoff A.L., DeLisi L.E., Csernansky J.G. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 2004, 68:1-9.
34. Hoff A., Rordan H., O'Donnell D., DeLisi L. Cross-sectional and longitudinal neuropsychological test findings in first episode schizophrenia. Schizophr. Res. 1991, 5:197-198.
35. Hong Kong Psychological Society The Wechsler Adult Intelligence Scale-Revised (Cantonese version) 1989, Hong Kong Psychological Society, Hong Kong.
36. Hong Kong Psychological Society The Wechsler Memory Scale-Revised (Cantonese version) 1989, Hong Kong Psychological Society, Hong Kong.
37. Hughes C., Kumari V., Soni W., et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr. Res. 2002, 59:137-146.
38. Kohler G.C., Walker J.B., Martin E.A., Healey K.M., Moberg P.J. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr. Bull. 2010, 36:1009-1019.
39. Konstantakopoulos G., Ploumpidis D., Oulis P., et al. Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophr. Res. 2011, 133:193-198.
40. Lataster T., Shazad A., Henquet C., et al. No evidence for familial covariation of neurocogition and negative symptoms in psychotic disorders. Schizophr. Res. 2012, 139:271-272.
41. Leeson V.C., Barnes T.R.E., Harrison M., et al. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr. Bull. 2010, 36:400-409.
42. Liemburg E., Castelein S., Stewart R., et al. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J. Psychiatr. Res. 2013, 47:718-725.
43. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62:975-983.
44. Messinger J.W., Tremeau F., Antonius D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31:161-168.
45. Mortimer A.M., McKenna P.J., Lund C.E., Mannuzza S. Rating of negative symptoms using the High Royds Evaluation of Negativity (HEN) Scale. Br. J. Psychiatry 1989, 155(Suppl. 7):89-91.
46. Murphy B.P., Chung Y.C., Park T.W., McGorry P.D. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr. Res. 2006, 88:5-25.
47. Oosthuizen P., Emsley R.A., Keyter N., Niehaus D.J., Koen L. Duration of untreated psychosis and outcome in first-episode psychosis: perspective from a developing country. Acta Psychiatr. Scand. 2005, 111:214-219.
48. Schuepbach D., Hill S.K., Sanders R.D., Hell D., Keshavan M.S., Sweeney J.A. Early treatment-induced improvement of negative symptoms predict cognitive functioning in treatment-naïve first episode schizophrenia: a 2-year follow-up. Schizophr. Bull. 2004, 30:837-848.
49. So E., Kam I., Leung C.M., Chung D., Liu Z., Fong S. The Chinese-bilingual SCID-I/P Project: Stage 1: reliability for mood disorders and schizophrenia. Hong Kong J. Psychiatry 2003, 13:7-18.
50. Strauss G.P., Horan W.P., Kirkpatrick B., et al. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J. Psychiatr. Res. 2013, 47:783-790.
51. Ucok A., Polat A., Genc A., Cakir S., Turan N. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J. Psychiatr. Res. 2004, 38:163-168.
52. Villalta-Gil V., Vilaplana M., Ochoa S., et al. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?. Schizophr. Res. 2006, 87:246-253.